Associations between good days per month and migraine-related disease impact in the real-world: a post hoc analysis from the REVIEW study of eptinezumab in chronic migraine
Abstract Background Data from the real-world REVIEW (Real-world EVidence and Insights into Experiences With eptinezumab) study demonstrated that, after starting treatment with eptinezumab, individuals with chronic migraine (CM) experienced double the number of good days per month and high rates of s...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-11-01
|
| coleção: | The Journal of Headache and Pain |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s10194-025-02227-5 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
